Benitec Biopharma Ltd Stock Price Patterns
| BNTC Stock | USD 12.60 0.42 3.45% |
Momentum 40
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter (0.33) | EPS Estimate Current Year (1.04) | EPS Estimate Next Year (0.92) | Wall Street Target Price 23.8333 | EPS Estimate Current Quarter (0.36) |
Using Benitec Biopharma hype-based prediction, you can estimate the value of Benitec Biopharma Ltd from the perspective of Benitec Biopharma response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Benitec Biopharma using Benitec Biopharma's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Benitec using crowd psychology based on the activity and movement of Benitec Biopharma's stock price.
Benitec Biopharma Short Interest
A significant increase or decrease in Benitec Biopharma's short interest from the previous month could be a good indicator of investor sentiment towards Benitec. Short interest can provide insight into the potential direction of Benitec Biopharma stock and how bullish or bearish investors feel about the market overall.
200 Day MA 13.4466 | Short Percent 0.1025 | Short Ratio 9.9 | Shares Short Prior Month 2 M | 50 Day MA 12.5276 |
Benitec Biopharma Hype to Price Pattern
Investor biases related to Benitec Biopharma's public news can be used to forecast risks associated with an investment in Benitec. The trend in average sentiment can be used to explain how an investor holding Benitec can time the market purely based on public headlines and social activities around Benitec Biopharma Ltd. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Benitec Biopharma's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Benitec Biopharma.
Benitec Biopharma Implied Volatility | 2.3 |
Benitec Biopharma's implied volatility exposes the market's sentiment of Benitec Biopharma Ltd stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Benitec Biopharma's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Benitec Biopharma stock will not fluctuate a lot when Benitec Biopharma's options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Benitec Biopharma to buy its stock at a price that has no basis in reality. In that case, they are not buying Benitec because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Benitec Biopharma after-hype prediction price | USD 12.56 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Benitec contract
Based on the Rule 16, the options market is currently suggesting that Benitec Biopharma Ltd will have an average daily up or down price movement of about 0.14% per day over the life of the 2026-04-17 option contract. With Benitec Biopharma trading at USD 12.6, that is roughly USD 0.0181 . If you think that the market is fully incorporating Benitec Biopharma's daily price movement you should consider acquiring Benitec Biopharma Ltd options at the current volatility level of 2.3%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out Benitec Biopharma Basic Forecasting Models to cross-verify your projections. Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Benitec Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Benitec Biopharma After-Hype Price Density Analysis
As far as predicting the price of Benitec Biopharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Benitec Biopharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Benitec Biopharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Benitec Biopharma Estimiated After-Hype Price Volatility
In the context of predicting Benitec Biopharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Benitec Biopharma's historical news coverage. Benitec Biopharma's after-hype downside and upside margins for the prediction period are 7.71 and 17.41, respectively. We have considered Benitec Biopharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Benitec Biopharma is somewhat reliable at this time. Analysis and calculation of next after-hype price of Benitec Biopharma is based on 3 months time horizon.
Benitec Biopharma Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Benitec Biopharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Benitec Biopharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Benitec Biopharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.23 | 4.85 | 0.04 | 0.05 | 11 Events / Month | 7 Events / Month | In about 11 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
12.60 | 12.56 | 0.32 |
|
Benitec Biopharma Hype Timeline
Benitec Biopharma is currently traded for 12.60. The entity has historical hype elasticity of -0.04, and average elasticity to hype of competition of -0.05. Benitec is anticipated to decline in value after the next headline, with the price expected to drop to 12.56. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.32%, whereas the daily expected return is currently at -0.23%. The volatility of related hype on Benitec Biopharma is about 2204.55%, with the expected price after the next announcement by competition of 12.55. About 82.0% of the company shares are held by institutions such as insurance companies. The book value of Benitec Biopharma was currently reported as 3.57. The company recorded a loss per share of 1.09. Benitec Biopharma last dividend was issued on the 18th of November 2019. The entity had 1:17 split on the 26th of July 2023. Given the investment horizon of 90 days the next anticipated press release will be in about 11 days. Check out Benitec Biopharma Basic Forecasting Models to cross-verify your projections.Benitec Biopharma Related Hype Analysis
Having access to credible news sources related to Benitec Biopharma's direct competition is more important than ever and may enhance your ability to predict Benitec Biopharma's future price movements. Getting to know how Benitec Biopharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Benitec Biopharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SLDB | Solid Biosciences LLC | 0.15 | 8 per month | 4.40 | 0.04 | 11.36 | (7.56) | 21.63 | |
| NGNE | Neurogene | (0.26) | 9 per month | 0.00 | (0.16) | 6.59 | (9.34) | 23.85 | |
| AUTL | Autolus Therapeutics | 0.13 | 8 per month | 0.00 | (0.03) | 10.45 | (8.67) | 30.76 | |
| QSI | QuantumSi | (0.02) | 7 per month | 0.00 | (0.24) | 6.50 | (8.00) | 15.95 | |
| PRTC | PureTech Health PLC | 0.00 | 6 per month | 2.51 | 0.03 | 4.53 | (4.58) | 14.71 | |
| LCTX | Lineage Cell Therapeutics | 0.05 | 9 per month | 0.00 | (0.07) | 4.65 | (5.73) | 15.77 | |
| XOMA | XOMA Corp | (1.39) | 10 per month | 0.00 | (0.09) | 5.27 | (4.97) | 29.87 | |
| IMAB | IMAB Old | (0.58) | 5 per month | 4.63 | 0.06 | 10.53 | (8.92) | 33.43 | |
| GALT | Galectin Therapeutics | (0.50) | 11 per month | 0.00 | (0.12) | 9.46 | (8.89) | 43.49 | |
| OCGN | Ocugen Inc | 0.22 | 10 per month | 4.40 | (0.01) | 7.25 | (7.43) | 32.50 |
Benitec Biopharma Additional Predictive Modules
Most predictive techniques to examine Benitec price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Benitec using various technical indicators. When you analyze Benitec charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Benitec Biopharma Predictive Indicators
The successful prediction of Benitec Biopharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Benitec Biopharma Ltd, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Benitec Biopharma based on analysis of Benitec Biopharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Benitec Biopharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Benitec Biopharma's related companies. | 2025 | 2026 (projected) | Dividend Yield | 0.001357 | 0.001206 | Price To Sales Ratio | 67.52 | 64.14 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Complementary Tools for Benitec Stock analysis
When running Benitec Biopharma's price analysis, check to measure Benitec Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Benitec Biopharma is operating at the current time. Most of Benitec Biopharma's value examination focuses on studying past and present price action to predict the probability of Benitec Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Benitec Biopharma's price. Additionally, you may evaluate how the addition of Benitec Biopharma to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |